N. Hay

NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma.

F. Sutcliffe, Andrew Stevens, C. Griffiths, 2011, The Lancet. Oncology.

Endovascular stent-grafts for the treatment of abdominal aortic aneurysms: NICE technology appraisal guidance

E George, N Hay, F McCracken, 2009, Heart.

NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma.

F. Sutcliffe, N. Hay, Sally Doss, 2011, The Lancet. Oncology.

NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer.

A. Adler, E. George, N. Hay, 2015, The Lancet. Oncology.